Neuroscientists at Virginia Tech’s Fralin Biomedical Research Institute at VTC will investigate how obesity influences brain ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

High sodium intake is linked to greater obesity risk, particularly in women, even when it comes from everyday foods. New ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

World Liver Day is an opportunity to spread awareness about mindful eating, healthy food for the liver, and screening in case ...

When a patient with obesity reports a new symptom, many physicians are quick to focus on the excess weight without exploring alternative reasons. Wrong approach, experts said.

Among the 2,225 adults in the study, all under 60 years of age, 39.7% had obesity as defined only by higher BMI, while 39.1% ...

Eli Lilly's new oral weight loss pill, orforglipron, shows promise in Phase 3 trials, offering a convenient alternative to ...

A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...

Nearly all U.S. adults with obesity as diagnosed by BMI also have an elevated waist circumference or excess body fat, ...

A groundbreaking daily pill could compete with weight-loss injections such as Ozempic, research suggests. In trials, people ...

Studies have also shown that sweeteners can stimulate the same neurons as the appetite hormone, leptin. Over time, this could ...